Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03230877 · ClinicalTrials.gov registry record
The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea
A clinical trial of Obstructive Sleep Apnea, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT03230877: Completed study of Obstructive Sleep Apnea, sponsored by Fisher and Paykel Healthcare.
NCT03230877 is a study of Obstructive Sleep Apnea that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 38 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03230877, a study of Obstructive Sleep Apnea, has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigation is a prospective, randomized, single blinded, crossover study. The investigation is designed to evaluate the performance, comfort and ease of use of the F\&P Trial Full Face Mask Seal amongst Obstructive Sleep Apnea (OSA) participants. A total number of 40-45 OSA participants will be recruited for the trial by the investigation site
Primary Outcome
Overall seal comfort determined from questionnaires- Subjective
Conditions Studied
Interventions
- DEVICE Toffee full face mask with 'Improved Seal'
- DEVICE Toffee full face mask with 'Normal Seal'
Study Locations (1)
Florida
- Clinical Trials of Florida - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-09-02 |
| Est. Completion | 2017-11-30 |
What the finished NCT03230877 record still lists
NCT03230877 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Toffee full face mask with 'Improved Seal' is the first listed.
NCT03230877 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03230877 about?
NCT03230877 is a clinical study titled "The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea". The investigation is a prospective, randomized, single blinded, crossover study. The investigation is designed to evaluate the performance, comfort and ease of use of the F\&P Trial Full Face Mask Seal amongst Obstructive Sleep Apnea (OSA) participants. A total number of 40-45 OSA participants will ...
What is the current status of trial NCT03230877?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2017-09-02. Estimated completion is 2017-11-30.
What conditions does trial NCT03230877 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT03230877?
The interventions under investigation include: Toffee full face mask with 'Improved Seal' (DEVICE), Toffee full face mask with 'Normal Seal' (DEVICE).
Who is sponsoring clinical trial NCT03230877?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03230877 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03230877's enrollment target sits among peer trials
38 119th of 155 higher than 36 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI